Navigation Links
Virginia G. Piper Cancer Center vaccine study hopes to improve pancreatic cancer treatment
Date:6/13/2014

SCOTTSDALE, Ariz. June 12, 2014 Medical investigators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are studying a new cancer immunotherapy to see if it can successfully help patients with advanced pancreatic cancer.

The Phase 2B clinical trial of CRS-207 and GVAX Pancreas vaccines is open at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with the Translational Genomics Research Institute (TGen), where cancer patients are treated with promising new drugs.

Participants in the study, named ECLIPSE (Efficacy of Combination Listeria/GVAX Immunotherapy in the Pancreatic Cancer Setting), will be randomized so patients receive only the CRS-207 vaccine, or that vaccine combined with the GVAX Pancreas vaccine and low doses of cyclophosphamide. A third group of patients will receive a standard chemotherapy.

"This is a very innovative approach using immunotherapy to treat pancreatic cancer," explained Dr. Erkut Borazanci, M.D., M.S., medical oncologist and Drug Development Scholar at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare and the study's lead investigator.

The CRS-207 vaccine is a weakened form of the bacteria, Listeria monocytogenes, that has been genetically modified to be safe for human use, while retaining its ability to stimulate the immune system. Specifically, CRS-207 has been engineered to stimulate an immune response against the tumor-associated antigen mesothelin, which is present at high levels on pancreatic cancer cells.

The GVAX vaccine is composed of genetically modified, inactivated pancreatic cancer cells that have been shown to stimulate the immune system's anticancer activity. The vaccine is given with a low-dose of a common cancer drug called cyclophosphamide to boost the effectiveness of the vaccine.

In a recently completed Phase 2A trial in 93 patients with advanced pancreatic cancer, survival was
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Virginia Tech updates football helmet ratings, 5 new helmets meet 5-star mark
2. Virginia Tech scientists out for blood when it comes to stopping malaria
3. Class Action Lawsuit Filed on Behalf of West Virginia Residents Affected by Recent Chemical Spill
4. West Virginia Business Owners Represented in Class Action Lawsuit over Elk River Chemical Spill
5. The Bell Law Firm Filing Class Action Complaints on Behalf of West Virginia Contaminated Water Victims
6. Virginia Tech researchers find novice teen drivers easily fall into distraction, accidents
7. The Science Museum of Virginia Receives Largest Private Gift in Its History
8. Audiologists at Virginia Hearing Consultants in Norfolk VA Share Warnings about Everyday Ototoxic Drugs
9. Audiologists at Maico Audiological Services in Newport News Virginia Advise Consumers about Drugs that Lead to Hearing Loss
10. Northern Virginia Real Estate Company Pasquali Realty Group Suggests These New Year’s Resolutions For Homeowners
11. Northern Virginia Real Estate Company Pasquali Realty Group Announces Prices Up in November
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... 02, 2015 , ... Maddock Douglas is an internationally recognized ... To help manage the increasing demand for innovation as a primary growth strategy, ... Strategic Engagements. , Benkendorf is a seasoned management executive with more than 25 ...
(Date:7/1/2015)... ... 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was ... has been recognised for his outstanding contribution to enhancing the world's production and distribution ... the World Food Prize Foundation, announced this year’s winner at a ceremony at the ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... term care, specialty, combo, and compounding pharmacy operations, announces the most recent positioning ... Cardinal Health RBC event at the Venetian Las Vegas, Nevada. ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families (CCF) ... The grant will allow CCF to improve quality of care and save costs for ... to respond to many changes in New York’s Medicaid system. Experts agree that children ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Did you know ... is Men’s Health Month, and we at Advanced Fertility Center of Texas (AFCT) would ... men. , While infertility is often considered to be a “woman’s issue,” male ...
Breaking Medicine News(10 mins):Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4
... more than just faithful companionship: A new study led by ... walked their dogs were 34 percent more likely to meet ... Mathew Reeves, show that promoting dog ownership and dog walking ... meet recommended levels of leisure-time physical activity become healthier. ...
... In an effort to improve treatment and one ... Foundation today joined with key donors and community leaders ... of globalCure is an alliance between TGen and the ... cancer scientists, physicians and researchers, armed with the most ...
... , WEDNESDAY, March 9 (HealthDay News) -- The U.S. ... new treatment option in more than 50 years when it approved ... debilitating autoimmune disorder. Injected directly into a vein, Benlysta is ... the number of abnormal B cells believed to be at the ...
... Two studies published by an interdisciplinary team of Hong ... Cell Transplantation (20:1), now freely available on-line at ... adult brain cells (neurogenesis) in two critical areas of ... a stress reducer and also to sexual behavior and ...
... , THURSDAY, March 10 (HealthDay News) -- ... bones that surgeons should adjust for when they perform ... researchers. Previous studies have found that cerebral palsy ... the hips, but this is the first study to ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, March ... diabetes were able to get injections of a new insulin drug ... findings still need to be confirmed in another phase of research, ... it were approved for this use. But those caveats aside, ...
Cached Medicine News:Health News:Grab the leash: Dog walkers more likely to reach exercise benchmarks 2Health News:TGen Foundation launches 'globalCure,' targets pancreatic cancer 2Health News:FDA Approves 1st New Lupus Drug in More Than 50 Years 2Health News:Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues 2Health News:Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues 3Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  MEI Pharma, ... the clinical development of novel therapies for cancer, announced today ... Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare ... time from Le Parker Meridien in ... can be accessed at www.meipharma.com . A replay will ...
(Date:7/1/2015)... Lupin , ... Number of MPP Sub-licensees to Fourteen Companies   ... the rapid expansion of its network of generic manufacturers to ... develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides Arcolab ... HIV medicine the MPP licensed from ViiV Healthcare two months ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
The seed alignment tray aligns seeds and spacers for easy access to be picked up by the SeedVac™. It also interfaces with the seed sterilization and sorting tray for protection from radiation....
MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...
... ACMI™ offers five classes of ... vaporization, cutting loops, knife, roller bar ... are the only electrodes specifically integrated ... surgical tissue removal with minimal bleeding, ...
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
Medicine Products: